Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: J Nucl Med. 2013 Jul 19;54(9):1621–1629. doi: 10.2967/jnumed.112.118539

Figure 5.

Figure 5

Effect of p53 status in p53 wild-type (A) and p53-null (B) tumors on survival of HCT116 tumor–bearing nude mice in treated and control groups. Estimated survival distribution function was generated using Kaplan–Meier time-to-death analysis. Median survivals of all treated and control groups with HCT116 +/+ and HCT116 −/− tumors are summarized in C. ***P < 0.001 vs. radioimmunotherapy group. **P < 0.01 vs. radioimmunotherapy group. RIT = radioimmunotherapy.